
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
05/20/2025 | Q1 | -- | $25M | -$0.98 | -- | -- |
12/31/2024 | Q4 | -- | $19.4M | $4.01 | -- | -- |
11/19/2024 | Q3 | -- | $31.1M | -$24.85 | -- | -- |
08/16/2024 | Q2 | -- | $28.4M | -$37.80 | -- | -- |
03/31/2024 | Q1 | -- | $38.4M | $2.36 | -- | -- |
12/31/2023 | Q4 | -- | $30.6M | -$783.30 | -- | -- |
09/30/2023 | Q3 | -- | $43.1M | -$3,481.80 | -- | -- |
06/30/2023 | Q2 | -- | $47.4M | -$43,574.30 | -- | -- |
03/31/2023 | Q1 | $34.4M | $28.9M | -$36,396.15 | -- | -- |
12/31/2022 | Q4 | -- | $30.5M | -$82,529.53 | -- | -- |
09/30/2022 | Q3 | $23.7M | $44.3M | -$6,658.75 | -$2,625.01 | -$4,033.74 |
06/30/2022 | Q2 | $27.8M | $17.4M | -$23,388.75 | -$2,625.01 | -$20,763.74 |
03/31/2022 | Q1 | $6.2M | $32.8M | -$33,578.76 | -$15,750.03 | -$17,828.73 |
12/31/2021 | Q4 | $9M | $7.8M | -$56,473.15 | -$15,750.03 | -$40,723.12 |
09/30/2021 | Q3 | -- | -$30.8M | -$201,362.87 | -- | -- |
06/30/2021 | Q2 | -- | $62.1M | $170,511.74 | -- | -- |
03/31/2021 | Q1 | -- | $13.2M | $26,393.62 | -- | -- |
12/31/2020 | Q4 | -- | $7.2M | -$45,542.86 | -- | -- |
09/30/2020 | Q3 | -- | $5.7M | -$389,255.81 | -- | -- |
06/30/2020 | Q2 | -- | $5.4M | -$59,956.52 | -- | -- |
03/31/2020 | Q1 | -- | $5.6M | -$326,800.40 | -- | -- |
12/31/2019 | Q4 | -- | $6.3M | -$986,546.25 | -- | -- |
09/30/2019 | Q3 | -- | $5.3M | -$1,149,572.78 | -- | -- |
06/30/2019 | Q2 | -- | $5M | -$1,354,727.00 | -- | -- |
03/31/2019 | Q1 | -- | $5.8M | -$6,680,479.00 | -- | -- |
12/31/2018 | Q4 | -- | $6.2M | -$11,835,507.00 | -- | -- |
09/30/2018 | Q3 | -- | $8.3M | -- | -- | -- |
06/30/2018 | Q2 | -- | $7.4M | -- | -- | -- |
03/31/2018 | Q1 | -- | $5.2M | -- | -- | -- |
12/31/2017 | Q4 | -- | $3.5M | -- | -- | -- |
09/30/2017 | Q3 | -- | $3.2M | -- | -- | -- |
06/30/2017 | Q2 | -- | $1.8M | -- | -- | -- |
03/31/2017 | Q1 | -- | $1.6M | -- | -- | -- |
12/31/2016 | Q4 | -- | $2M | -$27,300,000.25 | -- | -- |
09/30/2016 | Q3 | -- | $1.8M | -- | -- | -- |
06/30/2016 | Q2 | -- | $2.1M | -- | -- | -- |
03/31/2016 | Q1 | -- | $1.7M | -- | -- | -- |
12/31/2015 | Q4 | -- | $2.3M | -- | -- | -- |
09/30/2015 | Q3 | -- | $1.4M | -- | -- | -- |
Hyperscale Data reported $25M worth of top line sales in its most recent quarter.
Hyperscale Data announced earnings per share of -$0.98 which represents a miss of analyst forecast a -- per share.
Hyperscale Data reported $5.3M that represents $0.84 per share over the last quarter.
Hyperscale Data's earnings are forecast to grow from -$68.09 per share to -- per share next year representing an increase of --.
Hyperscale Data's next earnings date is August 15, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.